Agilent Technologies has delivered strong multi year gains, and a fresh push into AI enabled digital pathology software now puts a sharper spotlight on a simple question for you as a shareholder or prospective buyer: Is the current share price of US$169.90 adequately backed by the cash flows the business is expected to generate?
- Agilent’s share price has returned 58.9% over the past 3 years, which raises the stakes on whether that climb is fully supported by its underlying cash generation.
- The planned Proscia acquisition, valued at up to US$270 million, may support expectations for higher margin software revenue and potentially change the timing and durability of future cash flows.
- Prefer to judge Agilent Technologies on earnings? See why Agilent Technologies's 33.3x P/E tells a different valuation story.
The issue now is whether Agilent Technologies’ current valuation can be explained by the cash flows implied in that Discounted Cash Flow (DCF) intrinsic value estimate.
If you are weighing Agilent Technologies against other ways to play this AI driven lab tools and diagnostics theme, a focused stock screen is a clean starting point in the form of 33 healthcare AI stocks
Is Agilent Technologies Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here takes Agilent Technologies’ projected Free Cash Flow to Equity and discounts it back to today in dollar terms. Latest twelve month free cash flow sits at about $1.21b, and the projections used in the model assume that cash generation grows steadily over the next decade rather than surging or collapsing.
Those rising cash flow estimates, when discounted, imply an intrinsic value that the DCF model puts modestly above the current share price of US$169.90. Because the planned Proscia deal adds an AI driven software layer with its own margin profile and capital needs, the acquisition announced for up to $270 million helps explain why the cash flow outlook embedded in the DCF is constructive and why the market price may not fully reflect that case yet. Find out what Agilent Technologies could be worth using our Discounted Cash Flow (DCF) estimate.
The Agilent Technologies Narrative: What Would Justify Today's Price?
Narratives for Agilent Technologies pick up exactly where this valuation puzzle leaves you, by spelling out which paths for growth, profitability and earnings would need to play out for the current market value to look either stretched or conservative. Each scenario ties its number to a clear view on how Agilent Technologies' revenue trajectory, margin profile and key risks might evolve. You can check these scenarios against new information as it emerges, all hosted on Simply Wall St's Community page.
One of the top community narratives on Agilent Technologies: 6% undervalued
"Growth in high recurring revenue activities such as Agilent CrossLab services and consumables, which recently grew over 5% core and benefit from about 70%…"
Discover why this Narrative puts Agilent Technologies at 6% undervalued.
One more angle on Agilent Technologies that could shift your view
Cash flows and valuation models only tell part of the story, because the people steering Agilent Technologies and the way their rewards are structured can heavily influence where those future dollars go. See who runs Agilent Technologies and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com